Fred B. Davenport Jr., President at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 18,300 shares at $30.11 ($552K) on 2006-11-02, disclosed to the SEC on 2006-11-06.
Open-market sale of $552k PPDI by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.01 | 1,000 | $30K | 5.4% |
| 2 | $30.02 | 700 | $21K | 3.8% |
| 3 | $30.03 | 700 | $21K | 3.8% |
| 4 | $30.04 | 200 | $6K | 1.1% |
| 5 | $30.05 | 300 | $9K | 1.6% |
| 6 | $30.06 | 800 |
| $24K |
| 4.4% |
| 7 | $30.08 | 1,300 | $39K | 7.1% |
| 8 | $30.09 | 400 | $12K | 2.2% |
| 9 | $30.10 | 1,000 | $30K | 5.5% |
| 10 | $30.11 | 1,634 | $49K | 8.9% |
| 11 | $30.12 | 1,100 | $33K | 6.0% |
| 12 | $30.13 | 900 | $27K | 4.9% |
| 13 | $30.14 | 566 | $17K | 3.1% |
| 14 | $30.15 | 400 | $12K | 2.2% |
| 15 | $30.16 | 700 | $21K | 3.8% |
| 16 | $30.17 | 900 | $27K | 4.9% |
| 17 | $30.18 | 400 | $12K | 2.2% |
| 18 | $30.21 | 1,000 | $30K | 5.5% |
| 19 | $30.22 | 200 | $6K | 1.1% |
| 20 | $30.24 | 500 | $15K | 2.7% |
| 21 | $30.25 | 192 | $6K | 1.1% |
| 22 | $30.26 | 500 | $15K | 2.7% |
| 23 | $30.28 | 200 | $6K | 1.1% |
| 24 | $30.33 | 608 | $18K | 3.3% |
| 25 | $30.37 | 300 | $9K | 1.7% |
| 26 | $30.38 | 100 | $3K | 0.6% |
| 27 | $30.40 | 1,300 | $40K | 7.2% |
| 28 | $30.42 | 400 | $12K | 2.2% |
| Total | $30.16 avg | 18,300 | $552K | 100% |
| Filing → |
| MEDP | SELL | 2025-04-28 | $1.0M | — | Filing → |
| MEDP | BUY | 2022-02-22 | $73K | — | Filing → |
| PPDI | SELL | 2006-12-19 | $2.2M | — | Filing → |